Loading the section
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 16, 2026 | 57.04 | 57.78 | 56.33 | 56.78 | 2m |
| September 15, 2026 | 55.93 | 56.97 | 54.95 | 56.90 | 2m |
| September 14, 2026 | 56.44 | 57.07 | 55.91 | 56.21 | 2m |
| September 11, 2026 | 56.76 | 57.43 |
Based on reports through December 31, 2025
Exelixis is built around a single cancer drug and is widening its use.
The lead drug is used in kidney and liver cancer, often combined with immunotherapy. It supplies the overwhelming share of revenue, and the company is profitable — a rarity for a biotech. That dependence gives a steady stream today and a defined risk date in the future.
Work runs in two directions: widening the approved drug's indications and developing the next generation of molecules meant to replace it before patent protection lapses. Litigation with generic manufacturers is a constant background. Risks: the patent term, trial outcomes and competition in the same indications. The company pays no dividend but buys back stock.
Address:1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502, US
| 359m |
| TWSTTwist Bioscience Corporation | 155.56 | +8.73 % | 226m |
| HALOHalozyme Therapeutics, Inc. | 109.72 | +1.18 % | 211m |
| TECHBio-Techne Corp | 72.41 | +0.11 % | 192m |
| NBIXNeurocrine Biosciences, Inc. | 151.41 | +127.80 % | 173m |
| 54.55 |
| 56.12 |
| 3m |
| September 10, 2026 | 58.33 | 58.33 | 57.23 | 57.43 | 2m |
| September 09, 2026 | 57.60 | 58.36 | 56.95 | 58.33 | 2m |
| September 08, 2026 | 58.97 | 59.41 | 57.55 | 57.67 | 3m |
| September 04, 2026 | 58.50 | 59.26 | 58.46 | 59.01 | 2m |
| September 03, 2026 | 58.75 | 59.72 | 58.20 | 59.13 | 2m |
| September 02, 2026 | 57.21 | 59.11 | 56.70 | 58.53 | 3m |
| September 01, 2026 | 54.75 | 56.97 | 54.75 | 56.89 | 2m |
| August 31, 2026 | 54.10 | 55.02 | 53.43 | 54.64 | 2m |
| August 28, 2026 | 55.14 | 55.25 | 54.12 | 54.45 | 1m |
| August 27, 2026 | 55.76 | 56.08 | 54.83 | 55.26 | 1m |
| August 26, 2026 | 56.54 | 56.90 | 56.06 | 56.10 | 2m |
| August 25, 2026 | 54.95 | 56.74 | 54.95 | 56.72 | 2m |
| August 24, 2026 | 53.89 | 54.79 | 53.39 | 54.55 | 2m |
| August 21, 2026 | 53.74 | 54.68 | 53.70 | 54.08 | 2m |
| August 20, 2026 | 53.76 | 54.50 | 53.44 | 53.69 | 2m |
| August 19, 2026 | 53.46 | 54.58 | 53.10 | 54.39 | 3m |